← Back to All Stocks

Telomir Pharmaceuticals, Inc. (TELO) Analysis

Generated on: 2025-06-22 15:23:19 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 17,618,311 shares

Analysis Values

Current Price
$1.85
Predicted Price
$2.20
Expected Return
16.10%
Confidence Score
0.85
RSI (14)
42.26
MACD
-0.17
Volume
486,100
Float Shares
17,618,311
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249

TELO

Telomir Pharmaceuticals, Inc.
16.10%
Price: $1.85
Confidence: 0.85
News
Low Float
Last updated: 2025-06-22 15:23:18

Technical Analysis

RSI: 42.26
MACD: -0.17
Technical Analysis Graph

Risk Analysis

Volatility
120.52%
Max Drawdown
-77.55%
Beta
1.0
Risk Score
99.2

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria
Benzinga - 2025-06-18 13:00
Telomir Pharmaceuticals Inc. (NASDAQ:TELO) on Wednesday announced new preclinical data showing that its lead candidate, Telomir-1, prevented cellular aging in human progeria cell lines obtained from the Progeria Research Foundation. In this study, conducted by Smart Assays, Telomir-1 was tested in cells taken directly from a child with HGPS. The study evaluated cell viability, reactive oxygen species (ROS), and intracellular calcium signaling—a marker of mitochondrial dysfunction—under normal an

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.